| 中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
|---|---|---|---|---|
| 1-氯-2-[(4-硝基苯氧基)甲基]苯 | 2-chlorobenzyl-4-nitrophenyl ether | 56532-65-1 | C13H10ClNO3 | 263.68 |
| —— | N-[4-[(2-chlorophenyl)methoxy]phenyl]acetamide | 65890-78-0 | C15H14ClNO2 | 275.735 |
| 中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
|---|---|---|---|---|
| —— | 1-Chloro-2-[(4-isocyanatophenoxy)methyl]benzene | 1416442-84-6 | C14H10ClNO2 | 259.692 |
| —— | Ethyl 2-chloro-3-[4-[(2-chlorophenyl)methoxy]phenyl]propanoate | 57181-09-6 | C18H18Cl2O3 | 353.245 |
A series of 4-anilinoquinolinylchalcone derivatives were synthesized and evaluated for antiproliferative activities against the growth of human cancer cell lines (Huh-7 and MDA-MB-231) and normal lung cells (MRC-5). The results exhibited low cytotoxicity against human lung cells (MRC-5). Among them, (E)-3-4-[4-(benzyloxy)phenyl]amino}quinolin-2-yl}-1-(4-methoxyphenyl) prop-2-en-1-one (4a) was found to have the highest cytotoxicity in breast cancer cells and low cytotoxicity in normal cells. Compound 4a causes ATP depletion and apoptosis of breast cancer MDA-MB-231 cells and triggers reactive oxygen species (ROS)-dependent caspase 3/7 activation. In conclusion, it is worth studying 4-anilinoquinolinylchalcone derivatives further as new potential anticancer agents for the treatment of human cancers.